ngµç×ÓÓÎÏ·

03
½Ìѧ¿ÆÑÐ
  • 29 2024-05

    Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐÄÉñ¾­ÃâÒßÍŶӹØÓÚ×ÔÉíÃâÒßÐÔÄÔÑ×˯ÃßÕÏ°­Ñо¿Ð§¹ûÔÚNeurology½ÒÏþ

    ¿ËÈÕ£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐÄÉñ¾­ÃâÒßÍŶÓÔÚÉñ¾­²¡Ñ§×ÅÃûÆÚ¿¯Neurology£¨ÖпÆÔºÒ»Çø£¬Top£¬IF=9.9£©½ÒÏþÁËÌâΪ¡°Cardiopulmonary coupling spectrogram as an ambulatory method for assessing sleep disorders in patients with autoimmune encephalitis¡±µÄÑо¿ÂÛÎÄ¡£¡£¸ÃÑо¿Á¢ÒìÐԵؽ«CPCÓÃÓÚAEµÄ˯ÃßÆÀ¼Û£¬²¢·¢Ã÷ÁËAEµÄ˯ÃßÆÀ¹À±ê¼ÇÎÍØÕ¹ÁËAE˯ÃßÕÏ°­µÄÆÀ¹À˼Ð÷¡£¡£¸ÃÆÀ¹ÀÒªÁì¾ßÓбãЯ¡¢Ç³Òס¢¸ßЧµÄÌص㣬ÓÐÍûÓëÆä...

  • 29 2024-05

    ÁÖºÆÌí½ÌÊÚÍŶӺÍÅËáɸ±½ÌÊÚÑо¿ÍŶӻùÓÚÖÇÄÜÊÖÒյġ°ÑÛ¿ÆÐÂÐÍÈý¼¶ÕïÁÆģʽ¡±¿çѧ¿ÆÏàÖúÑо¿Ð§¹ûÔÚÏß½ÒÏþÓÚ¡¶×ÔÈ»-ͨѶ¡·

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±ÌÆÑÞÀö£© Åãͬ×ÅÈ«ÇòÉú³ÝÀÏÁ仯Ç÷ÊÆ£¬ÖÂϹÑÛ²¡µÈÂýÐÔ·ÇѬȾÐÔ¼²²¡Õ¼¼²²¡Æ×Ö÷Ҫְ룬ÔçÆÚÕï¶ÏºÍʵʱÖÎÀí¹ØÓÚÌá¸ß»¼ÕßµÄÉúÑÄÖÊÁ¿ºÍ¼õÇáÒ½ÁƼ縺ÖÁ¹ØÖ÷Òª¡£¡£ÒÔÌìÏÂÊ×λÖÂϹÑÛ²¡¡ª¡ª°×ÄÚÕÏΪÀý£¬µ½2050ÄêÖйú°×ÄÚÕÏʧÃ÷²¡ÀýÔ¤¼Æ½«µÖ´ï2000ÍòÀý¡£¡£È»¶ø£¬ÏÖÔÚÎÒ¹úÓÅÖÊÒ½ÁÆ×ÊÔ´Ïà¶ÔØÑ·¦ºÍϲãÒ½ÁÆ·þÎñÄÜÁ¦È±·¦µÄ½á¹¹ÐÔÄÑÌ⣬ֱ½ÓÖÆÔ¼ÁË°×ÄÚÕϵÈÖÂϹÑÛ²¡ÆÕ±éɸÕïµÄÓÐÓÿªÕ¹¡£¡£×÷Ϊº£ÄÚÒ»Á÷¸ßµÈѧ¸®£¬ngµç×ÓÓÎÏ·Æð¾¢Ì½Ë÷...

  • 24 2024-05

    ¹«¹²ÎÀÉúѧԺ£¨ÉîÛÚ£©Áõ˹Ñó¿ÎÌâ×éÕ¹ÏÖÈÑÉïÆÚѪС°å¼ÆÊý¼°ÑªÐ¡°åïÔÌ­Ö¢µÄÒªº¦ÒÅ´«»ùÒò

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±Áõ˹Ñó£©ÈÑÉïÆÚÊÇÈËÀà·±ÑܵÄÒªº¦Ê±ÆÚ¡£¡£¸¾Å®ÔÚÔÐÆڻᱬ·¢Ò»ÏµÁÐÐÄÀíת±äÒÔÖ§³ÖÌ¥¶ùµÄÉú³¤ºÍ·¢Óý¡£¡£ÆäÖУ¬Ôи¾µÄѪС°å¼ÆÊý»áÖð½¥Ï½µ£¬ÁÙÅèʱµÖ´ï×îµÍÖµ£¬²úºóÖð½¥»Ö¸´ÖÁÔÐǰˮƽ¡£¡£ÈÑÉïÆÚѪС°åïÔÌ­Ö¢£¨GT£©ÊÇÈÑÉïÆÚ³£¼ûµÄÒ»ÖÖѪҺϵͳ¼²²¡, ÌåÏÖΪѪС°å¼ÆÊýСÓÚ150¡Á109/L¡£¡£È«ÇòÿÄêÓÐÁè¼Ý900ÍòµÄGT»¼Õß¡£¡£GT»¼Õß²úºó´ó³öѪµÄ·çÏÕ»®·ÖÊÇÕý³£Ôи¾µÄ2-3.7±¶¡£¡£ÑªÐ¡°å¼ÆÊýÊÇÒ»¸ö¸ß¶È¿ÉÒÅ´«µÄ±íÐÍ£¬ÔÚ²î±ðÈËȺÖйÀ...

  • 23 2024-05

    ¡°ÖйúʽÏÖ´ú»¯µÄÀíÂÛÓëʵ¼ù¡±Ñ§Êõ×êÑлáôß¹ú¼ÒÉç¿Æ»ù½ðÖØ´óÏîÄ¿¿ªÌâ»áÀֳɾÙÐÐ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±µËÝÒÜð£©ÎªÏµÍ³¡¢ÉîÈëµØÑо¿ÖйúʽÏÖ´ú»¯µÄһϵÁÐÖØ´óÀíÂÛºÍʵ¼ùÎÊÌ⣬5ÔÂ12ÈÕ£¬ÓÉngµç×ÓÓÎÏ·Âí¿Ë˼Ö÷ÒåѧԺÖ÷ÀíµÄ¡°ÖйúʽÏÖ´ú»¯µÄÀíÂÛÓëʵ¼ù¡±Ñ§Êõ×êÑлáôß¹ú¼ÒÉç¿Æ»ù½ðÖØ´óÏîÄ¿¿ªÌâ»áÔÚÄÏУ԰»³Ê¿ÌþÙÐС£¡£¶àÃûר¼ÒѧÕßÆë¾ÛÒ»Ì㬾ÍÏà¹ØÎÊÌâÕö¿ªÉîÈë×êÑС£¡£ÂÛ̳¿ªÄ»Ê½ÓÉngµç×ÓÓÎÏ·µ³Î¯¸±Êé¼ÇÍõ·«½ÌÊÚÖ÷³Ö¡£¡£³Â´ºÉùÊé¼ÇÖ¿ªÄ»´Êngµç×ÓÓÎÏ·µ³Î¯Êé¼Ç³Â´ºÉù½ÌÊÚ³öϯÂÛ̳²¢Ö¿ªÄ»´Ç¡£¡£³Â´ºÉùÊé¼ÇÖ¸³ö£¬ÖйúʽÏÖ´ú»¯ÀíÂÛ...

  • 23 2024-05

    ngµç×ÓÓÎÏ·-º½Óî΢ ÓSoCоƬÁªºÏʵÑéÊÒÇ©Ô¼ôß½ÒÅÆÒÇʽÔÚÖ麣УÇø¾ÙÐÐ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±·½æ¡¢Ðí¼ÎÒð£©5ÔÂ17ÈÕ£¬ngµç×ÓÓÎÏ·-º½Óî΢ ÓSoCоƬÁªºÏʵÑéÊÒÇ©Ô¼ôß½ÒÅÆÒÇʽÔÚngµç×ÓÓÎÏ·Ö麣УÇøÈ˹¤ÖÇÄÜÑо¿Ôº´óÂ¥¾ÙÐС£¡£ngµç×ÓÓÎÏ·¸±Ð£³¤Ö£Ô¾¡¢Ö麣Êи±Êг¤ê˹ðÃ÷¡¢Ö麣º½Óî΢¿Æ¼¼¹É·ÝÓÐÏÞ¹«Ë¾ÐÅÓö­Ê³¤ÑÕ¾üµÈ³öϯǩԼÒÇʽ¡£¡£Ö£Ô¾¸±Ð£³¤ÔÚÖ´ÇÖÐÖ¸³ö£¬°ÙÄêngµç×ÓÓÎÏ·ÐγÉÁË¡°ÈýУÇøÎåУ԰¡±µÄ°ìѧÃûÌã¬ÊµÏÖÁËÎÄÀíÒ½¹¤Å©ÒÕ¶àѧ¿ÆÉî¶ÈÈÚºÏÓëЭͬ¿ªÕ¹£»£»£»ÒÔ΢µç×Ó¿ÆѧÓëÊÖÒÕѧԺΪ´ú±íµÄÉîÀ¶Ñ§¿ÆȺ£¬ÔÚѧУºÍÖ麣...

  • 22 2024-05

    ¶­Ñ¤ÀýÌÊÚÍŶӽÒÏþ´óÆø¿ÅÁ£ÎïÖÐÂÈ»¯Ê¯À¯Óë¶ùͯ¹ýÃôÐÔ¼²²¡ÕýÏà¹ØµÄ×îÐÂÑо¿Ð§¹û

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±»Æ¾¸ö©£©¿ËÈÕ£¬¹«¹²ÎÀÉúѧԺ¶­Ñ¤ÀýÌÊÚ¿ÎÌâ×éÔÚ¹ú¼ÊÆÚ¿¯Journal of Hazardous Materials£¨ÖпÆÔºÒ»Çø£¬IF=13.6£©ÉϽÒÏþÁËÌâΪPositive Association between Chlorinated Paraffins and the Risk of Allergic Diseases in Children and AdolescentsµÄ×îÐÂÑо¿Ð§¹û¡£¡£±¾Ñо¿ÔÚÇ°ÆÚÑо¿»ù´¡ÉÏÉîÈëÍØÕ¹£¬ÎªÍƽøÐÂÐͳ¤ÆÚÐÔÓлúÎÛȾÎïÂÈ»¯Ê¯À¯µÄ¿µ½¡·çÏÕÆÀ¹ÀºÍÏà¹ØÖÎÀíÌṩÁËеÄÈËȺÑо¿Ö¤¾Ý¡£¡£ÂÈ»¯Ê¯À¯£¨Chlorina...

  • 16 2024-05

    ˧ÐÄÌΡ¢Îº²¨½ÌÊÚÍŶÓÔÚJournal of Controlled releaseÉϽÒÏþ×îÐÂÑо¿Ð§¹û

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±¶¡¶«±ø£©½üÆÚ£¬Á¥ÊôµÚÈýҽԺ˧ÐÄÌΡ¢Îº²¨½ÌÊÚÍŶÓÔÚÒ©¼ÁѧÁìÓò¹ú¼Ê¶¥¼¶Ñ§ÊõÆÚ¿¯¡¶Journal of Controlled release¡·(IF=10.8)ÉϽÒÏþÌâΪ¡°Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer¡±µÄÔ­´´ÐÔÑо¿Ð§¹û¡£¡£½á³¦°©µÄ·¢²¡ÂÊÏÖÔÚÈÔ³ÊÉÏÉýÇ÷ÊÆ£¬Êdz£¼ûµÄÏû»¯µÀ¶ñÐÔÖ×ÁöÖ®Ò»¡£¡£¸ÎתÒÆÊǽ᳦°©×î³£¼û...

  • 15 2024-05

    »¯Ñ§Ñ§ÔºÖ£ÖÎÀ¤½ÌÊÚÍŶӵ¯ÐÔ¾§ÌåĤÑо¿Ð§¹ûÔÚNature½ÒÏþ

    ngµç×ÓÓÎÏ·ÐÂÎÅѶ£¨Í¨Ñ¶Ô±Áõ½¡Ñô£©¸ß½á¾§¶ÈÖÊÁϵĻúеÎïÀíÐÔÄÜÖ÷Ҫȡ¾öÓÚÆäȱÏݽṹ£¬È±ÏÝÌØÊâÊǾ§½çȱÏÝÑÏÖØÆÆËð¸ß½á¾§¶ÈÖÊÁϵĻúеÐÔÄÜ£¬¶ø×ÔÈ»ºÍºÏ³É¾§Ì¬ÖÊÁÏͨ³£Îª¶à¾§£¬¹Ê¾§Ì¬ÖÊÁÏ»úеÎȹÌÐÔ²»¸ß¡£¡£Í¬Ê±£¬Í¬Ä¾ÁÏ¡¢²£Á§ºÍËÜÁϵÈÒ»Ñù£¬¾§Ì¬ÖÊÁϵĻúеǿ¶È£¨ÖÊÁÏÔÚÍâÁ¦×÷ÓÃÏ·´¿¹ÆÆËðµÄÄÜÁ¦£©ÓëÈÍÐÔ£¨ÖÊÁÏÔÚÊܵ½ÍâÁ¦¹¥»÷ʱÎüÊÕÄÜÁ¿²¢·´¿¹¶ÏÁѵÄÄÜÁ¦£©Ï໥ÖÆÔ¼£¬ÔõÑù¸ÄÉƸ߽ᾧÖÊÁϵĴàÐÔ£¬Í¬²½ÔöÇ¿Æä»úеǿ¶ÈºÍÈÍÐÔΪ¾§Ì¬ÖÊÁÏÄ¿½ñÃæ...

¡¾ÍøÕ¾µØͼ¡¿